Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,723,400 | 2,243,200 | 1,224,600 | 2,386,700 | 1,250,200 |
| Marketable Securities | 1,228,800 | 1,665,800 | 2,313,400 | 2,041,700 | 1,974,000 |
| Receivables | 1,959,600 | 2,088,900 | 1,958,500 | 2,017,300 | 1,951,000 |
| Inventories | 776,700 | 770,200 | 929,900 | 916,600 | 931,700 |
| Other current assets | 2,221,300 | 2,174,500 | 1,214,500 | 1,356,700 | 1,325,200 |
| TOTAL | $7,909,800 | $8,942,600 | $7,640,900 | $8,719,000 | $7,432,100 |
| Non-Current Assets | |||||
| PPE Net | 3,077,500 | 3,013,800 | 3,601,200 | 3,538,900 | 3,409,000 |
| Investments And Advances | 2,615,300 | 3,271,000 | 3,066,500 | 2,254,300 | 2,062,300 |
| Intangibles | 9,430,500 | 8,695,900 | 8,826,400 | 8,819,100 | 8,831,600 |
| Other Non-Current Assets | 3,254,500 | 2,522,200 | 2,153,900 | 2,160,900 | 2,217,900 |
| TOTAL | $18,377,800 | $17,502,900 | $17,648,000 | $16,773,200 | $16,520,800 |
| Total Assets | $26,287,600 | $26,445,500 | $25,288,900 | $25,492,200 | $23,952,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 377,100 | 378,000 | 370,500 | 342,300 | 295,700 |
| Accrued Expenses | 2,318,000 | 2,435,000 | 2,861,200 | 2,578,500 | 2,633,700 |
| Other current liabilities | 88,600 | 97,200 | N/A | N/A | N/A |
| TOTAL | $3,210,900 | $3,148,700 | $3,295,200 | $3,174,900 | $3,152,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,948,500 | 5,943,200 | 5,936,500 | 5,931,100 | 5,928,400 |
| Other Non-Current Liabilities | 1,778,800 | 1,789,901 | 1,391,301 | 1,513,300 | 1,409,200 |
| TOTAL | $10,127,900 | $9,474,801 | $8,962,101 | $8,557,500 | $8,546,800 |
| Total Liabilities | $13,338,800 | $12,623,500 | $12,257,300 | $11,732,400 | $11,699,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 184,447 | 193,893 | 196,709 | 201,483 | 201,443 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | 16,182,800 | 17,026,700 | 16,257,000 | 16,944,100 | 15,499,500 |
| Other shareholders' equity | -257,100 | -227,800 | -248,500 | -255,200 | -268,900 |
| TOTAL | $12,948,800 | $13,822,000 | $13,031,600 | $13,759,800 | $12,253,700 |
| Total Liabilities And Equity | $26,287,600 | $26,445,500 | $25,288,900 | $25,492,200 | $23,952,900 |